Name: UMIN ID:
Unique ID issued by UMIN | UMIN000032674 |
---|---|
Receipt number | R000037257 |
Scientific Title | Multicenter clinical trials to determine the efficacy and safety of consolidation and maintenance therapy with ixazomib, lenalidomide, dexamethasone (IRd) therapy in patients with multiple myeloma after autologous stem cell transplantation. |
Date of disclosure of the study information | 2018/06/01 |
Last modified on | 2022/05/25 17:04:37 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/05/22 11:15:58 | ||
2 | Update | 2018/05/22 20:41:05 | Key secondary outcomes Key secondary outcomes |
|
3 | Update | 2019/05/23 17:08:39 | Primary outcomes Key secondary outcomes |
|
4 | Update | 2019/05/23 17:09:20 | Primary outcomes Key secondary outcomes |
|
5 | Update | 2019/05/23 17:10:05 | Key inclusion criteria |
|
6 | Update | 2020/05/30 15:31:10 | Key exclusion criteria Key exclusion criteria |
|
7 | Update | 2021/05/24 11:50:31 | Date of IRB Last follow-up date |
|
8 | Update | 2022/05/25 17:04:37 | Recruitment status |